Five Alarm Bio seeking funding to develop drugs targeting the chronic diseases of ageing
Live Forever Club - 12-Feb-2025Promising preclinical results suggest a clear path towards drug development
Previously the Live Forever Club – now more focused on campaigning for radical life extension in the UK
Company that develops drugs to slow down the ageing process
Visit website: http://www.fivealarmbio.com/
Details last updated 07-Nov-2020
Promising preclinical results suggest a clear path towards drug development
FAB1 compound reduces ageing markers in cells while FAB15 accelerates wound healing
No drug candidates yet, but great to see investors willing to support a broad attack on ageing
The company aims at treatments for a range of diseases associated with ageing and disabilities
Professor of Molecular Biogerontology at University of Birmingham Institute of Inflammation and Ageing, consultant, futurist, speaker